ASCVD Risk Estimator Plus

Downloads
Revenue

Description

The updated ASCVD Risk Estimator Plus uses up to date science and user feedback to help a clinician and patient build a customized risk lowering plan by estimating and monitoring change in 10-year ASCVD risk.
Use the app to:
• Estimate a patient’s initial 10-year ASCVD risk using the pooled cohort equation
• Receive an individualized, risk-based, intervention approach
• Project the impact of specific interventions on a patient’s risk
• Guide clinician-patient discussion around customizing an intervention plan
• Update risk at follow-up based on a patient’s response to therapy using the Million Hearts Longitudinal model
Advice from the app is derived from the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease, the 2018 ACC/AHA et.al Guideline on the Management of Blood Cholesterol, the 2017 ACC/AHA et.al Guideline on High Blood Pressure in Adults, the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk, and the 2016 Million Hearts Longitudinal ASCVD Risk Assessment Tool user guide. The information and recommendations in this app are meant to support clinical decision making. They are not meant to represent the only or best course of care, or replace clinical judgment. Therapeutic options should be determined after discussion between the patient and their care provider.
Hide Show More...

Screenshots

ASCVD Risk Estimator Plus FAQ

  • Is ASCVD Risk Estimator Plus free?

    Yes, ASCVD Risk Estimator Plus is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is ASCVD Risk Estimator Plus legit?

    🤔 The ASCVD Risk Estimator Plus app's quality is mixed. Some users are satisfied, while others report issues. Consider reading individual reviews for more context.

    Thanks for the vote

  • How much does ASCVD Risk Estimator Plus cost?

    ASCVD Risk Estimator Plus is free.

  • What is ASCVD Risk Estimator Plus revenue?

    To get estimated revenue of ASCVD Risk Estimator Plus app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating

4 out of 5

1 ratings in Russia

5 star
0
4 star
1
3 star
0
2 star
0
1 star
0
Ratings History

ASCVD Risk Estimator Plus Reviews

Update

DrTrack13 on

Russia

“Therapy impact” is not active after the last update.

Doesn't mention bariatric surgery.

mmmmnbdhdjchdhshdbd on

United States

Should include bariatric surgery recommendations for patients that qualify. There are quite a few studies looking at CV risk reduction after surgery. The data should be included in this app. This app appears to ignore a major factor that plays a role (obesity) in about 35% (conservatively) of patients.

Useless

Sunrayyy on

United States

Not calculating, waste time

Not working any longer

Good1981game on

United States

After all of the information is typed in, it is no longer calculating the current 10 yr risk percentage.

Entered age 50, got error

mikephl on

United States

It said the age had to be between 40 and 71

App needs updating

Jazmac on

United States

Please update the app to reflect that aspirin is no longer indicated for primary prevention!

Defective

BigGuy57 on

United States

The app returns an estimated risk based on current data. However the Therapy impact suggests various scenarios that are imprudent. Start HBP meds when the patient doesn’t have HBP. Or intensify Statins for patients whose risk is less than 7.5%

Totally inaccurate

jjmdoc on

United States

This new version has some serious flaws. In addition to being harder to navigate than previous versions, it gives seriously incorrect values for ASCVD risk - last two patients I profiled both came back at 1.1% 10 year risk which is just not possible in the population I am seeing. Last person had a total cholesterol of 334! And still came back as 1.1% risk. Please scrap this version and go back to the old one.

I miss old version

teresa,np on

United States

I miss the old version which included more details on statins with high/moderate vs low intensity statins. A little harder to use now.

Useful app

Internal Med Doc on

United States

The estimation of therapy impact is useful and can be shown to patients so they understand rationale of treatment. The biggest fault is that fields requiring numerical data defaults to letter keyboard. It should automatically bring up the numerical keyboard to ease the burden of data entry.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
Chart
Category
Rank
Top Free
246
Top Free
256
Top Free
271
Top Free
285
Top Free
307

ASCVD Risk Estimator Plus Competitors

Name
Sanford Guide
Infectious Diseases Treatment
USPSTF Prevention TaskForce
USPSTF Recommendations (ePSS)
ASCCP Management Guidelines
CDC Vaccine Schedules
VisualDx
Medical images & differentials
DynaMed
Confidence in Practice
Contraception
STI Tx Guide
ADA Standards of Care
AHA Guidelines On-The-Go

ASCVD Risk Estimator Plus Installs

Last 30 days

ASCVD Risk Estimator Plus Revenue

Last 30 days

ASCVD Risk Estimator Plus Revenue and Downloads

Gain valuable insights into ASCVD Risk Estimator Plus performance with our analytics.
Sign up now to access downloads, revenue, and more.